Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Trial of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment (AMBIZYGO)
This study is currently recruiting participants.
Study NCT00467883   Information provided by Assistance Publique - Hôpitaux de Paris
First Received: April 30, 2007   Last Updated: April 1, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Zygomycosis
More general conditions related to this trial
Mycoses
Interventions listed in this trial
Liposomal Amphotericin B
Additional drug interventions recognized in this trial
Abelcet
Amphotericin B
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antifungal
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services